Abstract
The skin reaction to radiation is regularly monitored in order to detect enhanced radiosensitivity of the patient, unexpected interactions (e.g. with drugs) or any inadvertent overdosage. It is important to distinguish secondary disease from radiation reaction to provide adequate treatment and to avoid unnecessary discontinuation of radiotherapy. A case of bullous eruption or blisters during radiotherapy of the breast is presented. Differential diagnoses bullous pemphigoid, pemphigus vulgaris, and bullous impetigo are discussed and treatment described.
Zusammenfassung
Die Hautreaktion wird während der Strahlentherapie kontinuierlich überwacht, um rechtzeitig eine erhöhte Strahlenempfindlichkeit der Patientin/des Patienten, eventuelle unerwartete Interaktionen mit Begleitmedikation oder eine unbemerkte Überdosierung zu erkennen. Zweiterkrankungen, die nicht Strahlentherapie-assoziiert sind, sollten von radiogenen Reaktionen differenziert werden, um sie adäquat behandeln zu können. Bullae sind nicht typisch für die akute Radiodermatitis. Die Differenzialdiagnosen bullöses Pemphigoid, Pemphigus vulgaris und bullöse Impetigo sowie deren Therapie werden diskutiert.
References
Aguado L, Marquina M, Pretel M et al (2009) Lesions of pemphigus vulgaris on irradiated skin. Clin Exp Dermatol 34:e148–e150
Andreassen CN, Alsner J, Overgaard J (2002) Does variability in normal tissue reactions after radiotherapy have a genetic basis—where and how to look for it? Radiother Oncol 64:131–140
Badri T, Hammami H, Lachkham A et al (2011) Radiotherapy-induced pemphigus vulgaris with autoantibodies targeting a 110 kDa epidermal antigen. Int J Dermatol 50:1475–1479
Cabrera-Rodriguez JJ, Munoz-Garcia JL, Quiros Rivero J et al (2011) Radio-induced bullous pemphigoid. Clin Transl Oncol12:66–68
Geria AN, Schwartz RA (2010) Impetigo update: new challenges in the era of methicillin resistance. Cutis 85:65–70
Hoeller U, Borgmann K, Bonacker M et al (2003) Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. Radiother Oncol 69:137–144
Melani L, Giomi B, Antiga E et al (2005) Radiation therapy as a trigger factor for initially localized bullous pemphigoid. Breast J 11:485–486
Mul VE, Geest AJ van, Pijls-Johannesma MC et al (2007) Radiation-induced bullous pemphigoid: a systematic review of an unusual radiation side effect. Radiother Oncol 82:5–9
NCI (2010) NCI Common Terminology Criteria for Adverse Events (CTCAE) v.4 http://ctep.cancer.gov. Accessed 05 Sept 2013
Pommier P, Gomez F, Sunyach MP et al (2004) Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol 22:1447–1453
Stanley JR, Amagai M (2006) Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med 355:1800–1810
Tucker SL, Turesson I, Thames HD (1992) Evidence for individual differences in the radiosensitivity of human skin. Eur J Cancer 28A:1783–1791
Compliance with ethical guidelines
Conflict of interest. U. Hoeller, T. Schubert, V. Budach, U. Trefzer, and M. Beyer state that there are no conflicts of interest.
The accompanying manuscript does not include studies on humans or animals.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Höller, U., Schubert, T., Budach, V. et al. Blisters—an unusual effect during radiotherapy. Strahlenther Onkol 189, 977–979 (2013). https://doi.org/10.1007/s00066-013-0444-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-013-0444-9